medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2017-5-132-140medsovet-1804Research ArticleРЕВМАТОЛОГИЯRHEUMATOLOGYСОВРЕМЕННЫЕ МЕЖДУНАРОДНЫЕ И НАЦИОНАЛЬНЫЕ РЕКОМЕНДАЦИИ ПО ВЕДЕНИЮ БОЛЬНЫХ ОСТЕОАРТРОЗОМ ВОПРОСЫ СТРАТЕГИИ И ТАКТИКИMODERN INTERNATIONAL AND NATIONAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH OSTEOARTHRITIS ISSUES OF STRATEGY AND TACTICSЧичасоваН. В.ChichasovaN. V.

Доктор медицинских наук,  профессор

MD, Prof.

Институт профессионального образования Первого Московского государственного медицинского университета имени И.М. СеченоваРоссияInstitute of Professional Education of Sechenov First Moscow State Medical UniversityRussian Federation20171105201705132140Copyright © Чичасова Н.В., 20172017Чичасова Н.В.Chichasova N.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/1804

В статье приведены современные международные и отечественные рекомендации по ведению больных остеоартрозом. Обсуждаются возможности уменьшения боли при ОА, влияния медленнодействующих  препаратов на структуры сустава, место комбинации хондроитина сульфата и глюкозамина в лечении ОА.

The article presents the current international and domestic guidelines for the management of patients with osteoarthritis. We discuss the possibilities of pain reduction in OA, the effects of slow drugs on the structures of the joint, the place the combination of chondroitin sulfate and glucosamine in treating OA.

остеоартрозсовременные рекомендациимедленнодействующие симптом-модифицирующие препаратыosteoarthritiscurrent recommendations slow-acting symptom-modifying drugsReferencesBijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet, 2011, 377: 2115-2126.Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet, 2011, 377: 2115-2126.Насонов Е.Л. (ред.) Ревматология. Национальное руководство. М.: ГЭОТАР-Медиа, 2015, 720 с.Насонов Е.Л. (ред.) Ревматология. Национальное руководство. М.: ГЭОТАР-Медиа, 2015, 720 с.Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull Health Organ, 2003, 81: 646-656.Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull Health Organ, 2003, 81: 646-656.Murray CJ, Vos T, Lozano R et al. Disabilityadjusted life-years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of disease Study 2010. Lancet, 2012, 380: 2197-2223.Murray CJ, Vos T, Lozano R et al. Disabilityadjusted life-years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of disease Study 2010. Lancet, 2012, 380: 2197-2223.Галушко Е.А., Большакова Т.В., Виноградова И.Б. и др. Структура ревматических заболеваний среди взрослого населения России по данным эпидемиологического исследования (предварительные результаты). Научно-практ. Ревматология, 2009, 1: 11-17.Галушко Е.А., Большакова Т.В., Виноградова И.Б. и др. Структура ревматических заболеваний среди взрослого населения России по данным эпидемиологического исследования (предварительные результаты). Научно-практ. Ревматология, 2009, 1: 11-17.Pereira D, Peleteiro D, Araujo J et al. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthr Cartilage, 2011, 19: 1279-1285.Pereira D, Peleteiro D, Araujo J et al. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthr Cartilage, 2011, 19: 1279-1285.Vos T, Flaman AD, Naghavi M et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of disease Study 2010. Lancet, 2012, 380: 2163-2196.Vos T, Flaman AD, Naghavi M et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of disease Study 2010. Lancet, 2012, 380: 2163-2196.Juni P, Dieppe P, Donovan J et al. Population requirement for primary knee replacement surgery: a cross-sectional study. Rheumatol (Oxf ), 2003, 42: 516-21.Juni P, Dieppe P, Donovan J et al. Population requirement for primary knee replacement surgery: a cross-sectional study. Rheumatol (Oxf ), 2003, 42: 516-21.Jordan KM, Arden NK, Doherty M. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2003, 62: 1145-1155.Jordan KM, Arden NK, Doherty M. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2003, 62: 1145-1155.Dawson J, Linsell L, Zondervan K et al. Impact of persistent hip or knee pain overall health status in elderly people: a longitudinal population study. Arthr Care Res, 2005, 53: 368-374.Dawson J, Linsell L, Zondervan K et al. Impact of persistent hip or knee pain overall health status in elderly people: a longitudinal population study. Arthr Care Res, 2005, 53: 368-374.Верткин А.Л., Алексеева Л.И., Наумов А.В. и др. Остеоартроз в практике врача-терапевта. РМЖ, 2008, 16(7): 33-37.Верткин А.Л., Алексеева Л.И., Наумов А.В. и др. Остеоартроз в практике врача-терапевта. РМЖ, 2008, 16(7): 33-37.van Dijk GV, Veenhof C, Schelleviset S, et al. Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC. Musculoskelet Disord, 2008, 9: 95.van Dijk GV, Veenhof C, Schelleviset S, et al. Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC. Musculoskelet Disord, 2008, 9: 95.Каратеев А.Е., Насонов Е.Л., Яхно Н.Н. и соавт. Рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике. Клинические рекомендации. М.: ИМА-ПРЕСС, 2015. 36 с.Каратеев А.Е., Насонов Е.Л., Яхно Н.Н. и соавт. Рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике. Клинические рекомендации. М.: ИМА-ПРЕСС, 2015. 36 с.Helin-Salmivaara A et al. Risk of upper gastrointestinal events with the use of various NSAIDs: A case-control study in a general population. Scand J Gastroenterology, 2007, 428: 923-932.Helin-Salmivaara A et al. Risk of upper gastrointestinal events with the use of various NSAIDs: A case-control study in a general population. Scand J Gastroenterology, 2007, 428: 923-932.Jordan KM, Arden NK, Doherty M. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2003, 62: 1145-1155.Jordan KM, Arden NK, Doherty M. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2003, 62: 1145-1155.Hochberg MC, Altman RD, April KT et al. American College of Rheumatology 2012 recommendation for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res, 2012, 64: 465-474.Hochberg MC, Altman RD, April KT et al. American College of Rheumatology 2012 recommendation for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res, 2012, 64: 465-474.Zhang W, Moskowitz RW, Nuki G et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Ostearthr Cartilage, 2007, 15: 981-1000.Zhang W, Moskowitz RW, Nuki G et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Ostearthr Cartilage, 2007, 15: 981-1000.Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based expert consensus guidelines. Ostearthr Cartilage, 2008, 16: 137-62.Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based expert consensus guidelines. Ostearthr Cartilage, 2008, 16: 137-62.Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendation for the management of hip and knee osteoarthritis, part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartilage, 2010, 18: 476-499.Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendation for the management of hip and knee osteoarthritis, part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartilage, 2010, 18: 476-499.McAlindon TE, Bannuru RR, Sullivan MC et al. OARSI Guidelines for the non-surgical management of knee osteoarthritis. Ostearthr Cartilage, 2014, 22: 363-388.McAlindon TE, Bannuru RR, Sullivan MC et al. OARSI Guidelines for the non-surgical management of knee osteoarthritis. Ostearthr Cartilage, 2014, 22: 363-388.Bruyere O, Cooper CC, Pelletier J-P et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Sem Arthr Rheum, 2014, 44: 252-263.Bruyere O, Cooper CC, Pelletier J-P et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Sem Arthr Rheum, 2014, 44: 252-263.

The authors declare that there are no conflicts of interest present.